|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
-0.91/0.55
|
企業價值
291.92M
|
資產負債 |
每股賬面淨值
1.28
|
現金流量 |
現金流量率
--
|
損益表 |
收益
239.23K
|
每股收益
0.00
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2024/05/15 04:52 EDT
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. |